Science Explorer Back to mapMap
Discussion
Topic · Infectious Diseases

Infectious Disease Case Reports and Treatments

Infectious Disease Case Reports and Treatments is a research topic within Infectious Diseases. Science Explorer counts 7k research works in it since 1950. 10.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the pathogenesis, diagnosis, treatment, and management of Rhodococcus equi infections, particularly in foals. It covers topics such as pneumonia, virulence plasmids, immunity, and clinical outcomes.

  • Rhodococcus equi
  • infections
  • pneumonia
  • foals
  • diagnosis
  • treatment
  • virulence
  • plasmid
  • immunity
  • management
Research works
7k
fractional, since 1950
In the world top 10%
719
per year above
Top-10% rate
10.2%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+13%
the tick is no change
Largest producer
United States
30% of the 10 largest, 2022-now
Infectious Disease Case Reports and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Infectious Disease Case Reports and Treatments research?

By volume, the United States and China publish the most (247 and 149 works in 2022-now).

By volume, 2022-now

  1. 1 United States 247 works
  2. 2 China 149 works
  3. 3 India 147 works
  4. 4 Japan 88 works
  5. 5 Spain 38 works
  6. 6 Germany 37 works
  7. 7 United Kingdom 36 works
  8. 8 France 33 works
  9. 9 Türkiye 31 works
  10. 10 Morocco 29 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 29.6%China: 17.9%India: 17.6%Japan: 10.5%6 others listed: 24.4%30%largest
United States247 · 29.6%China149 · 17.9%India147 · 17.6%Japan88 · 10.5%6 others listed204 · 24.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Infectious Disease Case Reports and Treatments research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Infectious Disease Case Reports and Treatments research, followed by Mayo Clinic and Sichuan University.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 13 works
  2. 2 Mayo ClinicUnited States 6 works
  3. 3 Sichuan UniversityChina 6 works
  4. 4 Capital Medical UniversityChina 5 works
  5. 5 Peking UniversityChina 5 works
  6. 6 Centre Hospitalier Universitaire Ibn RochdMorocco 5 works
  7. 7 Johns Hopkins UniversityUnited States 5 works
  8. 8 Post Graduate Institute of Medical Education and ResearchIndia 5 works
  9. 9 Mexican Social Security InstituteMexico 5 works
  10. 10 Banaras Hindu UniversityIndia 5 works

Who are the leading researchers in Infectious Disease Case Reports and Treatments?

The most-cited researchers publishing on Infectious Disease Case Reports and Treatments include Bert Vogelstein, Kenneth W. Kinzler and Didier Raoult.

  1. 1 Bert Vogelstein United States 373k citations
  2. 2 Kenneth W. Kinzler United States 253k citations
  3. 3 Didier Raoult France 232k citations
  4. 4 Rinaldo Bellomo Australia 182k citations
  5. 5 Vivekanand Jha India 180k citations
  6. 6 Kwok‐Yung Yuen China 168k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Infectious Disease Case Reports and Treatments?

The most cited paper in Infectious Disease Case Reports and Treatments is "Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial" (GHJ Mickisch, A. Garin, Hendrik Van Poppel et al., 2001), with 1,424 citations. Next come "Bladder cancer: Epidemiology, staging and grading, and diagnosis" (1,093) and "Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)" (983).

Most cited papers
#PaperReleasedCitations
1 Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial GHJ Mickisch, A. Garin, Hendrik Van Poppel et al. · The Lancet Sep 2001 1,424
2 Bladder cancer: Epidemiology, staging and grading, and diagnosis Ziya Kırkalı, Theresa Chan, Murugesan Manoharan et al. · Urology Dec 2005 1,093
3 Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi) Joëlle Nortier, Marie-Carmen Muniz Martinez, Heinz H. Schmeiser et al. · New England Journal of Medicine Open access 8 Jun 2000 983
4 Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli Matthew A. Mulvey, Yolanda S. López-Boado, Carole L. Wilson et al. · Science 20 Nov 1998 962
5 Uncomplicated Urinary Tract Infection Thomas M. Hooton · New England Journal of Medicine 14 Mar 2012 891
All 100 most cited papers, with filters and sorting

Where is Infectious Disease Case Reports and Treatments research done?

The largest centres of Infectious Disease Case Reports and Treatments research in 2022-now are Tokyo (Japan), Beijing (China), New Delhi (India) and Paris (France). Among places with at least 20 works in it, it is an unusually large share of all research in Tokyo.

Largest cities, 2022-now

  1. 1 TokyoJapan 25 works
  2. 2 BeijingChina 22 works
  3. 3 New DelhiIndia 16 works
  4. 4 ParisFrance 12 works
  5. 5 New YorkUnited States 11 works
  6. 6 SeoulSouth Korea 9 works
  7. 7 ChengduChina 9 works
  8. 8 LondonUnited Kingdom 9 works
  9. 9 Mexico CityMexico 9 works
  10. 10 MadridSpain 8 works

Where it is the local speciality

  1. TokyoJP · 24.9 works2.6×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Infectious Disease Case Reports and Treatments than the world average.

See Infectious Disease Case Reports and Treatments on the map

Where is the best place to study Infectious Disease Case Reports and Treatments?

Among universities, judged by research, All India Institute of Medical Sciences score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1All India Institute of Medical SciencesIndia 3.06.6%10.6×12 -8.2%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Infectious Disease Case Reports and Treatments, country by country

Is Infectious Disease Case Reports and Treatments research growing?

Output in 2022-2025 was 13% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Infectious Disease Case Reports and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Infectious Disease Case Reports and Treatments as a percentage of every work published that year, 0.0045% in 2024.

still counting0.0050%0.010%0.015%Infectious Disease Case Reports and Treatments0.0050% in 202519801990200020102020

Fractional works of Infectious Disease Case Reports and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Infectious Disease Case Reports and Treatments10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Infectious Disease Case Reports and Treatments. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.